National Research Corp (NRC) - Revenue and Sales Volume

Exclusive access to patient satisfaction data creates a powerful defensive moat for National Research (NRC). The company's actual sales confirm this resilience, with the 0.14 mark recording this metric. Revenue growth relies on the SaaS scalability of cloud services, while income predictability is guaranteed by mandatory regulatory reporting for hospitals, ensuring a steady stream of subscription-based funds.

NRC - National Research Corp. Company Sales over the range 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for National Research Corporation (NRC)

- current price and projected stock value:

Share Price nrchealth.com|NRC - Analyst Consensus Forecast

- market capitalization indicators:

Market Capitalization National Research Corporation|NRC - Total Company Value

- company book value details:

Net Assets per Single Share NRC Health|NRC - Company Net Assets|Market Value to Book Value nrchealth.com|NRC - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and market ratios statistics:

NRC - Company Net Income|Expected Net Income National Research|NRC - P/E Multiple|Projected Price to Earnings National Research|NRC - PEG Multiple|Business Value to Operating Income Before Depreciation National Research Corporation|NRC - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months NRC Health|NRC - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months nrchealth.com|NRC - Earnings growth in current year|Expected earnings per share growth for next year National Research

- issuer revenue and sales details:

NRC - Revenue and Sales Volume|Company Future Sales National Research Corporation|NRC - Market Cap to Revenue|Price to Expected Revenue Ratio National Research Corporation

Comprehensive company analysis:National Research

Flagship merchandise of National Research

The business's margin of safety is determined by its ability to generate a stable cash flow. National Research (NRC) ensures revenue stability through its status as the industry standard in CAHPS and high switching costs for clinics. The company's total realization trend reflects the aggregate volume of services provided, stripped of market noise. Growth in this metric confirms expanding market expansion. This asset is characterized by a high degree of fundamental reliability.

Key competitors